Mertens J C, Geier A, Müllhaupt B
Swiss HPB (Hepato-Pancreato-Biliary) Center, Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich, Zürich.
Praxis (Bern 1994). 2010 Aug 25;99(17):1015-28. doi: 10.1024/1661-8157/a000223.
The treatment of chronic hepatitis C and B has become more and more complex over the last years. Individualisation of therapy, depending of the natural history as well as on treatment response, is increasingly finding its way into clinical practice. In addition, a significant number of new molecules active, against the hepatitis C virus, are currently in clinical evaluation. The goal of this review is to provide an up-to-date overview on the current treatment options for patients with a chronic viral hepatitis.
在过去几年中，慢性丙型肝炎和乙型肝炎的治疗变得越来越复杂。根据自然病史以及治疗反应进行个体化治疗，越来越多地应用于临床实践。此外，目前有大量针对丙型肝炎病毒的新型活性分子正在进行临床评估。本综述的目的是提供一份关于慢性病毒性肝炎患者当前治疗选择的最新概述。
